Literature DB >> 9700149

Mechanisms of proliferative and obliterative vascular diseases. Insights from the pulmonary and systemic circulations. NHLBI Workshop summary.

A P Fishman1, M C Fishman, B A Freeman, M A Gimbrone, M Rabinovitch, D Robinson, D B Gail.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9700149     DOI： 10.1164/ajrccm.158.2.9803084

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  3 in total

1.  Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.

Authors:  Lahouaria Hadri; Razmig G Kratlian; Ludovic Benard; Bradley A Maron; Peter Dorfmüller; Dennis Ladage; Christophe Guignabert; Kiyotake Ishikawa; Jaume Aguero; Borja Ibanez; Irene C Turnbull; Erik Kohlbrenner; Lifan Liang; Krisztina Zsebo; Marc Humbert; Jean-Sébastien Hulot; Yoshiaki Kawase; Roger J Hajjar; Jane A Leopold
Journal:  Circulation       Date:  2013-06-26       Impact factor: 29.690

2.  Simvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive rats.

Authors:  Bin Liu; Xiao-qin Wang; Li Yu; Tong-fu Zhou; Xian-min Wang; Han-min Liu
Journal:  Exp Lung Res       Date:  2009-06       Impact factor: 2.459

Review 3.  Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation.

Authors:  Seiichiro Sakao; Koichiro Tatsumi; Norbert F Voelkel
Journal:  Respir Res       Date:  2009-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.